Diplomatic tension grows between Nicaragua and Spain

Diplomatic tension grows between Nicaragua and Spain

Diplomatic tension grows between Nicaragua and Spain Credit: Pixabay

Diplomatic tension grows between Nicaragua and Spain after Foreign Ministry criticises the arrests of Ortega’s opponents.

The government of Nicaragua has criticised the Spanish government after it recalled Maria del Mar Fernandez-Palacios, the Spanish ambassador who had been in Managua. The Spanish government has rejected all the “accusations” which were made in a statement by Daniel Ortega’s regime on Tuesday.

Only hours after the Spanish Foreign Ministry announced the recall of Fernandez-Palacios for consultations, the Nicaraguan Foreign Ministry hit out with a new message for the Spanish government. In this message they highlighted that everything they said in the first note stands, including that Spain is continuously interfering in the internal affairs of Managua.

The Nicaraguan Foreign Ministry said: “In that communication, only truths were told, and that is precisely what irritates the honourable Kingdom of Spain.

They also added: “We demand that Spain comply with all its obligations in terms of human rights and democracy, in a non-repressive legal framework that guarantees the social, political, electoral and citizens’ processes in this Spain that looks so arrogant, boastful and false”.

In other Spanish news, Spanish vaccine approved for first human clinical trial. This is the first Spanish made vaccine that has made it to the human trial stage.

The Spanish Agency for Medicines and Health Products (AEMPS), which reports to the Ministry of Health, have given the go-ahead for first human clinical trial of the PHH-1V vaccine against the coronavirus. The vaccine is made by the company Hipra and this is the first human trial for a Spanish vaccine.

Several hospitals will take part in the trial and volunteers will be selected as soon as possible. Volunteers will need to be between 18 and 39 years of age.

The trial will see volunteers divided into groups, the first of which will be given the lowest dose of the vaccine. The data will then be assessed by an independent monitoring commission. Further doses could then be given if there are no safety concerns. This first stage of the trial aims to find the optimal vaccine dose.


Thank you for reading, and don’t forget to check The Euro Weekly News for all your up-to-date local and international news stories.

 

Alex
Written by

Alex Glenn

Originally from the UK, Alex is based in Almeria and is a web reporter for The Euro Weekly News covering international and Spanish national news. Got a news story you want to share? Then get in touch at editorial@euroweeklynews.com.

Comments